Lv1
60 积分 2025-06-21 加入
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors
7小时前
已完结
Identification of Novel pan-KRAS Inhibitors via Structure-Based Drug Design, Scaffold Hopping, and Biological Evaluation
8小时前
已完结
Mucosal vaccination in mice provides protection from diverse respiratory threats
13天前
已完结
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS
1个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
1个月前
已完结
Intratumoural vaccination via checkpoint degradation-coupled antigen presentation
2个月前
已完结
CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity
2个月前
已完结
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
2个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
2个月前
已完结
In Situ Chimeric Antigen Receptor Macrophage Therapy via Co-Delivery of mRNA and Immunostimulant
2个月前
已完结
皖公网安备34019202002308
